Carol L. Ensinger

835 total citations
10 papers, 242 citations indexed

About

Carol L. Ensinger is a scholar working on Molecular Biology, Organic Chemistry and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Carol L. Ensinger has authored 10 papers receiving a total of 242 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Organic Chemistry and 2 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Carol L. Ensinger's work include Adenosine and Purinergic Signaling (2 papers), Receptor Mechanisms and Signaling (2 papers) and Synthesis and Catalytic Reactions (2 papers). Carol L. Ensinger is often cited by papers focused on Adenosine and Purinergic Signaling (2 papers), Receptor Mechanisms and Signaling (2 papers) and Synthesis and Catalytic Reactions (2 papers). Carol L. Ensinger collaborates with scholars based in United States and Switzerland. Carol L. Ensinger's co-authors include Daniel D. Sternbach, Ruth R. Wexler, Pieter B.M.W.M. Timmermans, Andrew T. Chiu, Eric T. Whalley, Russell C. Petter, Joy Wang, Hairuo Peng, Hexi Chang and Herman van Vlijmen and has published in prestigious journals such as Journal of Medicinal Chemistry, The Journal of Organic Chemistry and Pharmaceutical Research.

In The Last Decade

Carol L. Ensinger

10 papers receiving 224 citations

Peers

Countries citing papers authored by Carol L. Ensinger

Since Specialization

Citations

This map shows the geographic impact of Carol L. Ensinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carol L. Ensinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carol L. Ensinger more than expected).

Fields of papers citing papers by Carol L. Ensinger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carol L. Ensinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carol L. Ensinger. The network helps show where Carol L. Ensinger may publish in the future.

Co-authorship network of co-authors of Carol L. Ensinger

This figure shows the co-authorship network connecting the top 25 collaborators of Carol L. Ensinger. A scholar is included among the top collaborators of Carol L. Ensinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carol L. Ensinger. Carol L. Ensinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	Switch control pocket inhibitors of p38-MAP kinase. Durable type II inhibitors that do not require binding into the canonical ATP hinge region 2010 ·Bioorganic & Medicinal Chemistry Letters ·Yu Mi Ahn, Michael Clare, Carol L. Ensinger, Molly M. Hood, John Lord, Wei-Ping Lu, David F. Miller, William C. Patt, Bryan D. Smith, Lakshminarayana Vogeti, Michael D. Kaufman, Peter A. Petillo, Scott Wise, Jan Abendroth, Lawrence Chun, Robin Clark, M.D. Feese, Hidong Kim, Lance Stewart, Daniel L. Flynn	26
2	Novel Bicyclic Piperazine Derivatives of Triazolotriazine and Triazolopyrimidines as Highly Potent and Selective Adenosine A₂_AReceptor Antagonists 2004 ·Journal of Medicinal Chemistry ·Hairuo Peng, G. Kumaravel, Gang Yao, Sha Li, Joy Wang, Herman van Vlijmen, Tonika Bohnert, (unknown), Chi B. Vu, Carol L. Ensinger, Hexi Chang, Thomas M. Engber, Eric T. Whalley, Russell C. Petter	54
3	Syntheses and biological evaluation of vinblastine congeners 2003 ·Organic & Biomolecular Chemistry ·Martin E. Kuehne, William G. Bornmann, István E. Markó, Yong Qin, (unknown), (unknown), Feng Xu, (unknown), Carol L. Ensinger, (unknown), (unknown), Christopher Exon, Fred T. Bizzarro, (unknown), Susan Bane	40
4	Synthesis of an o-Nitrobenzyl Attached A₁ Adenosine Receptor Antagonist, a Prodrug Approach 2003 ·Synthetic Communications ·Hexi Chang, Carol L. Ensinger, (unknown), (unknown)	1
5	Prodrugs to Improve the Oral Bioavailability of a Diacidic Nonpeptide Angiotensin II Antagonist 1995 ·Pharmaceutical Research ·Bruce J. Aungst, (unknown), Nancy J. Rogers, Hiroshi Saitoh, (unknown), Carol L. Ensinger, James R. Pruitt	7
6	Pictet-Spengler reaction in trifluoroacetic acid. Large scale synthesis of pyridoindolobenzodiazepine as an atypical antipsychotic agent 1995 ·Tetrahedron Letters ·Linhua Zhang, Walter Meier, (unknown), T. Costello, Phillip Ma, Carol L. Ensinger, (unknown), (unknown), P. Rajagopalan	24
7	Balanced angiotensin II receptor antagonists. III. The effects of substitution at the imidazole 5-position. 1994 ·Bioorganic & Medicinal Chemistry Letters ·Joseph B. Santella, John V. Duncia, Carol L. Ensinger, (unknown), David J. Carini, Ruth R. Wexler, Andrew T. Chiu, Pancras C. Wong, Pieter B.M.W.M. Timmermans	14
8	Nonpeptide angiotensin II receptor antagonists: the discovery of DMP 581 and DMP 811 1994 ·Bioorganic & Medicinal Chemistry Letters ·David J. Carini, Robert Ardecky, Carol L. Ensinger, James R. Pruitt, Ruth R. Wexler, Pancras C. Wong, Shiew‐Mei Huang, Bruce J. Aungst, Pieter B.M.W.M. Timmermans	16
9	A novel series of selective, non-peptide inhibitors of angiotensin II binding to the AT2 site 1993 ·Journal of Medicinal Chemistry ·(unknown), Carol L. Ensinger, Andrew T. Chiu, Dale E. McCall, Tâm Nguyễn, Ruth R. Wexler, Pieter B.M.W.M. Timmermans	24
10	Synthesis of polyquinanes. 3. The total synthesis of (.+-.)-hirsutene: the intramolecular Diels-Alder approach 1990 ·The Journal of Organic Chemistry ·Daniel D. Sternbach, Carol L. Ensinger	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact